Cellinfinity Bio
Cellinfinity Bio is dedicated to harnessing evolution for genetic reprogramming of immune cells in the body, providing innovative solutions to overcome barriers in solid tumor cell therapy. They focus on evolving immune cells to improve tumor infiltration, potency, and persistence, using principles of evolution such as scFv, vector, CAR, and genomic evolution.
Industries
Nr. of Employees
small (1-50)
Cellinfinity Bio
Milford, Connecticut, United States, North America
Products
Supercharged In Vivo Cell Therapy™
A simplified in vivo CAR-T cell therapy platform that allows the patient's own body to produce the therapy without the need for complex manufacturing or lymphodepletion.
Supercharged In Vivo Cell Therapy™
A simplified in vivo CAR-T cell therapy platform that allows the patient's own body to produce the therapy without the need for complex manufacturing or lymphodepletion.
Services
Platform for discovery and engineering of antibody fragments, delivery vectors, CAR constructs, and genetic enhancements intended to reprogram patient immune cells in situ for treatment of solid tumors.
Platform for discovery and engineering of antibody fragments, delivery vectors, CAR constructs, and genetic enhancements intended to reprogram patient immune cells in situ for treatment of solid tumors.
Expertise Areas
- In vivo cell therapy development
- Cell engineering and genetic programming
- Antibody-fragment discovery and engineering
- Vector design and in vivo delivery
Key Technologies
- In vivo gene-delivery vectors
- Directed evolution / evolutionary engineering
- scFv (single-chain variable fragment) engineering
- Chimeric antigen receptor (CAR) engineering